Skip to main content
Article thumbnail
Location of Repository

The Nuclear Transcription Factor CREB: Involvement in Addiction, Deletion Models and Looking Forward

By Cameron S McPherson and Andrew J Lawrence


Addiction involves complex physiological processes, and is characterised not only by broad phenotypic and behavioural traits, but also by ongoing molecular and cellular adaptations. In recent years, increasingly effective and novel techniques have been developed to unravel the molecular implications of addiction. Increasing evidence has supported a contribution of the nuclear transcription factor CREB in the development of addiction, both in contribution to phenotype and expression in brain regions critical to various aspects of drug-seeking behaviour and drug reward. Abstracting from this, models have exploited these data by removing the CREB gene from the developing or developed mouse, to crucially determine its impact upon addiction-related processes. More recent models, however, hold greater promise in unveiling the contribution of CREB to disorders such as addiction

Topics: Article
Publisher: Bentham Science Publishers Ltd.
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1998). 5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine.
  2. (2001). A CamKIIalpha iCre BAC allows brainspecific gene inactivation.
  3. (1997). A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Brain Res.
  4. (1998). A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
  5. (1997). A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission.
  6. (2000). Addiction, dopamine, and the molecular mechanisms of memory.
  7. (2002). Adeno-associated virus effectively mediates conditional gene modification in the brain.
  8. (2003). Alpha complementation in the Cre recombinase enzyme.
  9. (2005). Alterations in morphine-induced reward, locomotor activity, and thermoregulation in CREB-deficient mice.
  10. (1999). Altered emotional and locomotor responses in mice deficient in the transcription factor CREM.
  11. (2001). Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens.
  12. (1994). Amphetamine regulates gene expression in rat striatum via transcription factor CREB.
  13. (1974). An opponent-process theory of motivation. I. Temporal dynamics of affect.
  14. (2006). Antisenseinduced reduction in nucleus accumbens cyclic AMP response element binding protein attenuates cocaine reinforcement.
  15. (2002). Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB.
  16. (2002). Behavioral analysis of CREB alphadelta mutation on a B6/129 F1 hybrid background.
  17. (1999). Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
  18. (1987). Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene.
  19. (1997). Brief expression of a GFP cre fusion gene in embryonic stem cells allows rapid retrieval of site-specific genomic deletions.
  20. (2004). cAMP response element-binding protein is required for stress but not cocaine-induced reinstatement.
  21. (2001). cAMP response elementbinding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum.
  22. (2002). CART promoter CRE site binds phosphorylated CREB.
  23. (2006). Changes in accumbal and pallidal pCREB and deltaFosB in morphinesensitized rats: correlations with receptor-evoked electrophysiological measures in the ventral pallidum.
  24. (2006). Changes of CREB in rat hippocampus, prefrontal cortex and nucleus accumbens during three phases of morphine induced conditioned place preference in rats.
  25. (1998). Chronic ethanol administration decreases phosphorylation of cyclic AMP response elementbinding protein in granule cells of rat cerebellum.
  26. (2007). Cocaine-but not methamphetamine-associated memory requires de novo protein synthesis.
  27. (2002). Common molecular and cellular substrates of addiction and memory.
  28. (2002). Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage.
  29. (1997). CREB (cAMP response elementbinding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence.
  30. (2002). CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli.
  31. (2006). CREB modulates excitability of nucleus accumbens neurons.
  32. (1999). CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals.
  33. (2005). DARPP-32 genomic fragments drive Cre expression in postnatal striatum.
  34. (1994). Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein.
  35. (1998). Deficits in memory tasks of mice with CREB mutations depend on gene dosage.
  36. (2001). Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo.
  37. (2004). DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res.
  38. (2006). Different neural substrates mediate cocaine seeking after abstinence versus extinction training: a critical role for the dorsolateral caudate-putamen.
  39. (2001). Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse.
  40. (2004). Differential control over cocaine-seeking behavior by nucleus accumbens core and shell.
  41. (2003). Differential distribution of CREB in the mesolimbic dopamine reward pathway.
  42. (2006). Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus.
  43. (2002). Disruption of CREB function in brain leads to neurodegeneration.
  44. (2003). Does cAMP response element-binding protein have a pivotal role in hippocampal synaptic plasticity and hippocampus-dependent memory?
  45. (2003). Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum.
  46. (2004). Dorsal telencephalon-specific expression of Cre recombinase in PAC transgenic mice.
  47. (2001). Effects of chronic ethanol intake and its withdrawal on the expression and phosphorylation of the creb gene transcription factor in rat cortex.
  48. (1999). Effects of excitotoxic lesions of the rat prefrontal cortex on CREB regulation and presynaptic markers of dopamine and amino acid function in the nucleus accumbens.
  49. (2001). Effects of protracted nicotine exposure and withdrawal on the expression and phosphorylation of the CREB gene transcription factor in rat brain.
  50. (2001). Effects of voluntary ethanol intake on the expression of Ca(2+) /calmodulin-dependent protein kinase IV and on CREB expression and phosphorylation in the rat nucleus accumbens.
  51. (2004). Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors.
  52. (2002). Efficient in vitro and in vivo excision of floxed sequences with a high-capacity adenoviral vector expressing Cre recombinase.
  53. (2001). Emx1 is a marker for pyramidal neurons of the cerebral cortex.
  54. (1993). Engineered leucine zippers show that hemiphosphorylated CREB complexes are transcriptionally active.
  55. (1997). Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization.
  56. (2002). ER-based double iCre fusion protein allows partial recombination in forebrain.
  57. (2006). Ethanol activates cAMP response element-mediated gene expression in select regions of the mouse brain.
  58. (1996). Ethanol exposure alters the phosphorylation of cyclic AMP responsive element binding protein and cyclic AMP responsive element binding activity in rat cerebellum.
  59. (2001). Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect.
  60. (1995). Forskolin induces preproenkephalin and preprodynorphin mRNA in rat striatum as demonstrated by in situ hybridization histochemistry.
  61. (1999). Generalized lacZ expression with the ROSA26 Cre reporter strain.
  62. (1998). Genetic analysis of drug addiction: the role of cAMP response element binding protein.
  63. (2001). Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells.
  64. (2004). Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity.
  65. (2000). Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids.
  66. (2006). Impaired bidirectional synaptic plasticity and procedural memory formation in striatum-specific cAMP response elementbinding protein-deficient mice.
  67. (1998). Impaired fetal T cell development and perinatal lethality in mice lacking the cAMP response element binding protein.
  68. (2002). Inducible and brain region-specific CREB transgenic mice.
  69. (1999). Inducible site-specific recombination in the brain.
  70. (1998). Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaineseeking behavior.
  71. (2005). Involvement of the dorsal striatum in cue-controlled cocaine seeking.
  72. (2004). Memory and addiction: shared neural circuitry and molecular mechanisms.
  73. (2006). Methamphetamine-induced sensitization differentially alters pCREB and delta-FosB throughout the limbic circuit of the mammalian brain.
  74. (2004). Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice.
  75. (2004). Modulation of CREB expression and phosphorylation in the rat nucleus accumbens during nicotine exposure and withdrawal.
  76. (2002). Molecular Genetic Approaches. In:
  77. (2004). Molecular mechanisms of drug addiction.
  78. (1995). Molecular mechanisms of drug reinforcement and addiction.
  79. (1997). Molecular mechanisms of opiate and cocaine addiction.
  80. (2001). Molecular neurobiology of addiction.
  81. (2004). Molecular neurobiology of drug addiction.
  82. (2005). Mu-opioid receptor and CREB activation are required for nicotine reward.
  83. (1998). Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation.
  84. (1995). Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum.
  85. (1998). Neuroscience of addiction.
  86. (2004). Neurotrophin-3 and a CREB-mediated signaling pathway regulate Bcl-2 expression in oligodendrocyte progenitor cells.
  87. (1995). Nicotine elicits changes in expression of adrenal catecholamine biosynthetic enzymes, neuropeptide Y and immediate early genes by injection but not continuous administration. Brain Res.
  88. (1997). NMDA and D1 receptors regulate the phosphorylation of CREB and the induction of c-fos in striatal neurons in primary culture.
  89. (2003). Ohmefentanyl stereoisomers induce changes of CREB phosphorylation in hippocampus of mice in conditioned place preference paradigm.
  90. (1997). Opponent process model and psychostimulant addiction.
  91. (2004). Overexpression of CREB reduces CRE-mediated transcription: behavioral and cellular analyses in transgenic mice.
  92. (2004). Partial deletion of the cAMP response element-binding protein gene promotes alcohol-drinking behaviors.
  93. (1999). Potential role of the gene transcription factor cyclic AMP-responsive element binding protein in ethanol withdrawal-related anxiety.
  94. (1996). Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB.
  95. (2002). Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal.
  96. (1998). Regulation of cocaine reward by CREB.
  97. (1996). Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens.
  98. (1992). Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus.
  99. (2005). Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area.
  100. (2003). Regulation of gene expression and cocaine reward by CREB and DeltaFosB.
  101. (2002). Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory.
  102. (2006). Role of cAMP response elementbinding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors.
  103. (2002). Role of proto-oncogenes in the regulation of proenkephalin mRNA expression induced by repeated nicotine injections in rat adrenal medulla.
  104. (2001). Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity.
  105. (2002). Spatial and temporal profile of haloperidol-induced immediate-early gene expression and phosphoCREB binding in the dorsal and ventral striatum of amphetamine-sensitized rats.
  106. (1996). Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene.
  107. (1997). Targeted expression of Cre recombinase to adipose tissue of transgenic mice directs adipose-specific excision of loxP-flanked gene segments.
  108. (1994). Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors.
  109. (2000). Targeting of cre to the Foxg1 (BF-1) locus mediates loxP recombination in the telencephalon and other developing head structures.
  110. (1996). Targeting of the CREB gene leads to up-regulation of a novel CREB mRNA isoform.
  111. (1991). The basolateral amygdala-ventral striatal system and conditioned place preference: further evidence of limbic-striatal interactions underlying reward-related processes.
  112. (2003). The decreased phosphorylation of cyclic adenosine monophosphate (cAMP) response element binding (CREB) protein in the central amygdala acts as a molecular substrate for anxiety related to ethanol withdrawal in rats.
  113. (1999). The effects of continuous cocaine dose on the induction of behavioral tolerance and dopamine autoreceptor function.
  114. (1991). The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference.
  115. (2005). The many faces of CREB.
  116. (1995). The mind of an addicted brain: neural sensitization of wanting versus liking.
  117. (2001). The neurobiology of slow synaptic transmission.
  118. (2002). The neuroscience of natural rewards: relevance to addictive drugs.
  119. (2000). The psychology and neurobiology of addiction: an incentive-sensitization view.
  120. (2004). The role of DARPP-32 in the actions of drugs of abuse.
  121. (1988). The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
  122. (2001). Transcriptional regulation by the phosphorylation-dependent factor CREB.
  123. (2003). Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
  124. (1988). Two adjacent promoter elements mediate nerve growth factor activation of the c-fos gene and bind distinct nuclear complexes.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.